Join the Fight
Against Illegal Diversion!

Through our Reducing Illegal Diversion program, The Harvard Drug Group is dedicated to providing the latest information and tools to help combat Illegal Diversion.

Illegal Diversion Indicators
Pharmacy Research Results
Additional Diversion Resources
Click here to learn more

Recent News

12/3/10 - With drug's FDA approval, Sagent expands oncology portfolio
The Food and Drug Administration has approved a generic chemotherapy drug made by Sagent Pharmaceuticals, Sagent said Thursday.